The Epidemiology of Posttraumatic Osteoarthritis of the Knee in the United States: An Analysis of 948,853 Patients From 2000 to 2022.
Nicholas C BankParshva SanghviChristian J HechtR Justin MistovichPublished in: The Journal of the American Academy of Orthopaedic Surgeons (2024)
These findings echo earlier, smaller scale studies but reveal an alarming rise in PTOAK prevalence, potentially doubling by 2030. The financial burden of knee OA treatment in the United States is already substantial, costing between $5.7 and $15 billion USD annually. This projected increase in prevalence could further increase healthcare expenditures by $1 to 3 billion by 2030. These results emphasize the need for additional research into factors contributing to PTOAK, evidence-based preventive public health interventions, and the development of multidisciplinary system-based care delivery optimization pathways.
Keyphrases
- knee osteoarthritis
- risk factors
- healthcare
- public health
- total knee arthroplasty
- palliative care
- magnetic resonance
- affordable care act
- climate change
- physical activity
- anterior cruciate ligament
- anterior cruciate ligament reconstruction
- genome wide
- single cell
- health insurance
- magnetic resonance imaging
- computed tomography
- pain management
- diffusion weighted
- gene expression
- contrast enhanced
- social media
- global health
- childhood cancer